Hepatic Veno-Occlusive Disease and Colorectal Cancer: Expect the Unexpected.

hepatic veno-occlusive disease portal hypertension syndrome

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
04 Jul 2024
Historique:
received: 23 05 2024
revised: 15 06 2024
accepted: 28 06 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a rare liver vascular condition, potentially life-threatening, with clinical signs of portal hypertension, frequently reported in relation to bone marrow transplantation and possibly in non-transplantation-related chemotherapy. We report the case of a 65-year-old female patient who insidiously developed fatigue, mild tenderness of the right upper abdominal quadrant, hepato-splenomegaly and slight weight gain consecutive to ascites development, as well as persistent elevation of transaminases and mild thrombocytopenia. To note, she had a previous history of colorectal cancer (CRC) with liver metastases and several courses of chemotherapy. Abdominal duplex and elastography measurements made the diagnosis of cirrhosis improbable. A lot of lab work-ups were performed in order to rule out several diseases and conditions. Further, transjugular access was used to perform the measurement of the hepatic venous pressure gradient and liver biopsy that confirmed SOS/VOD. In late 2023, she was diagnosed with endometrial adenocarcinoma, requiring chemotherapy again. At present, the liver condition is stationary, but the prognosis is, however, uncertain. In conclusion, we presented the atypical case of a female patient who developed portal hypertension syndrome associated with the late onset of SOS/VOD, after 5-fluorouracil and oxaliplatin chemotherapy for CRC and liver metastases, subsequently diagnosed with endometrial adenocarcinoma, which posed many diagnostic and therapeutic challenges. Given the potentially bad outcome, an early diagnosis of SOS/VOD in patients receiving drugs of risk is important not only to stratify further risk, but also to initiate an appropriate therapy in order to improve the prognosis.

Identifiants

pubmed: 39063599
pii: life14070845
doi: 10.3390/life14070845
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Auteurs

Doina Georgescu (D)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Daniel Florin Lighezan (DF)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Ana Lascu (A)

Department of Functional Sciences, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Roxana Buzas (R)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Alexandra Faur (A)

Department of Anatomy and Embriology, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Ioana Ionita (I)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Ciprian Ilie Rosca (CI)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Ioana Suceava (I)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Despina Calamar-Popovici (D)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Mihai Ionita (M)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Oana Elena Ancusa (OE)

Department of Internal Medicine I, "V Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Classifications MeSH